Insider Trading activities at Vertex Pharmaceuticals Inc / Ma (VRTX) , Part 6

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vertex Pharmaceuticals Inc / Ma (VRTX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vertex Pharmaceuticals Inc / Ma. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 875320.

Total stock buying since 2014: $14,032,945.
Total stock sales since 2014: $1,196,910,074.
Total stock option exercises since 2014: $345,948,365.


28 insiders reported insider trading activities at Vertex Pharmaceuticals Inc / Ma (VRTX):
Insider trading activities of Parini Michael
Insider trading activities of Bhatia Sangeeta N.
Insider trading activities of Boger Joshua S
Insider trading activities of Ambrose Kristen
Insider trading activities of Altshuler David
Insider trading activities of Kearney Terrence C
Insider trading activities of Lee Yuchun
Insider trading activities of Sanna Bastiano
Insider trading activities of Sachs Bruce I
Insider trading activities of Carney Lloyd
Insider trading activities of Smith Ian F
Insider trading activities of Mcglynn Margaret G
Insider trading activities of Kewalramani Reshma
Insider trading activities of Liu Joy
Insider trading activities of Wagner Charles F Jr
Insider trading activities of Young William D
Insider trading activities of Tatsis Ourania
Insider trading activities of Ullian Elaine
Insider trading activities of Silva Paul M
Insider trading activities of Atkinson Edward Morrow Iii
Insider trading activities of Sachdev Amit
Insider trading activities of Arbuckle Stuart A
Insider trading activities of Bozic Carmen
Insider trading activities of Graney Thomas
Insider trading activities of Biller Jonathan
Insider trading activities of Leiden Jeffrey M
Insider trading activities of Riley Wayne Joseph
Insider trading activities of Chodakewitz Jeffrey

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Vertex Pharmaceuticals Inc / Ma (VRTX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 15,000 $5,843,150 36,186 $17,560,365 0 $0
2024 0 $0 148,610 $67,869,390 14,306 $1,623,040
2023 0 $0 293,658 $101,547,730 106,203 $13,301,242
2022 0 $0 299,056 $84,212,962 129,539 $14,304,907
2021 25,000 $4,926,050 80,192 $17,017,085 3,884 $336,043
2020 15,000 $3,263,745 823,381 $212,996,253 593,830 $68,989,498
2019 0 $0 749,106 $142,436,412 640,272 $64,836,003
2018 0 $0 677,893 $111,360,024 569,594 $48,688,330
2017 0 $0 1,829,749 $255,631,975 1,303,112 $81,084,922
2016 0 $0 425,204 $38,606,160 329,295 $11,861,367
2015 0 $0 1,169,000 $146,404,893 1,011,116 $40,701,778
2014 0 $0 10,500 $1,266,825 10,500 $221,235


Table 3. Detailed insider trading at Vertex Pharmaceuticals Inc / Ma (VRTX) , Part 6
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-01-05 Bhatia Sangeeta N. (Director) Option Ex 10,753 126.68 1,362,190
2018-01-02 Graney Thomas (Chief Financial Officer) Sale 777 149.95 116,511
2018-01-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 3,438 151.34 520,324
2018-01-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 3,438 73.51 252,727
2017-12-27 Silva Paul M (SVP & Corp Controller) Sale 1,289 152.31 196,327
2017-12-27 Silva Paul M (SVP & Corp Controller) Option Ex 1,289 77.31 99,652
2017-12-11 Leiden Jeffrey M (CEO & President) Sale 125,000 141.81 17,726,875
2017-11-15 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 221 147.29 32,551
2017-11-15 Altshuler David (EVP, Global Research and CSO) Sale 306 148.75 45,519
2017-11-15 Silva Paul M (SVP & Corp Controller) Sale 23 147.29 3,387
2017-11-15 Sachdev Amit (EVP, CRO) Sale 83 147.29 12,225
2017-11-15 Smith Ian F (EVP, COO) Sale 7 147.29 1,031
2017-11-06 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 4,250 148.17 629,722
2017-11-06 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 4,250 77.31 328,567
2017-11-06 Smith Ian F (EVP, COO) Sale 4,250 150.00 637,500
2017-11-06 Smith Ian F (EVP, COO) Option Ex 4,250 77.31 328,567
2017-11-03 Parini Michael (EVP, CL&AO) Sale 2,330 149.50 348,335
2017-11-03 Parini Michael (EVP, CL&AO) Option Ex 2,330 86.52 201,591
2017-11-03 Bhatia Sangeeta N. (Director) Sale 7,073 143.05 1,011,792
2017-11-03 Bhatia Sangeeta N. (Director) Option Ex 7,073 93.51 661,396
2017-11-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 3,594 144.69 520,015
2017-11-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 3,594 109.14 392,249
2017-11-03 Smith Ian F (EVP, COO) Sale 2,155 150.00 323,250
2017-11-03 Smith Ian F (EVP, COO) Option Ex 2,155 91.05 196,212
2017-11-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 1,796 144.77 260,012
2017-11-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 1,796 91.05 163,525
2017-10-31 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 60,000 145.95 8,756,760
2017-10-31 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 75,000 146.00 10,949,625
2017-10-31 Sachdev Amit (EVP, CRO) Sale 40,000 145.94 5,837,720
2017-10-31 Smith Ian F (EVP, COO) Sale 75,000 145.87 10,940,550
2017-10-27 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 6,290 145.21 913,339
2017-10-27 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 96.87 205,848
2017-10-16 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 1,718 155.37 266,925
2017-10-16 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 1,718 96.87 166,422
2017-10-16 Smith Ian F (EVP, COO) Sale 2,125 155.59 330,622
2017-10-16 Smith Ian F (EVP, COO) Option Ex 2,125 96.87 205,848
2017-10-12 Parini Michael (EVP, CL&AO) Sale 2,125 152.93 324,976
2017-10-12 Parini Michael (EVP, CL&AO) Option Ex 2,125 90.29 191,866
2017-10-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 3,437 151.83 521,829
2017-10-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 3,437 73.51 252,653
2017-08-31 Altshuler David (EVP, Global Research and CSO) Sale 1,796 160.00 287,360
2017-08-31 Altshuler David (EVP, Global Research and CSO) Option Ex 1,796 91.05 163,525
2017-08-07 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 4,250 152.88 649,740
2017-08-07 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 4,250 77.31 328,567
2017-08-07 Silva Paul M (SVP & Corp Controller) Sale 1,289 152.88 197,062
2017-08-07 Silva Paul M (SVP & Corp Controller) Option Ex 1,289 77.31 99,652
2017-08-07 Smith Ian F (EVP, CFO & COO) Sale 4,250 155.13 659,315
2017-08-07 Smith Ian F (EVP, CFO & COO) Option Ex 4,250 77.31 328,567
2017-08-03 Parini Michael (EVP, CL&AO) Sale 2,330 155.72 362,827
2017-08-03 Parini Michael (EVP, CL&AO) Option Ex 2,330 86.52 201,591
2017-08-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 3,594 154.22 554,255
2017-08-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 3,594 109.14 392,249
2017-08-03 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 4,250 155.72 661,810
2017-08-03 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 4,250 109.14 463,845
2017-08-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 1,796 154.39 277,284
2017-08-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 1,796 91.05 163,525
2017-08-02 Silva Paul M (SVP & Corp Controller) Sale 1,289 151.80 195,670
2017-08-02 Silva Paul M (SVP & Corp Controller) Option Ex 1,289 91.05 117,363
2017-08-02 Smith Ian F (EVP, CFO & COO) Sale 2,155 154.18 332,247
2017-08-02 Smith Ian F (EVP, CFO & COO) Option Ex 2,155 91.05 196,212
2017-07-31 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,125 152.99 325,103
2017-07-31 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 83.36 177,140
2017-07-31 Silva Paul M (SVP & Corp Controller) Sale 860 152.99 131,571
2017-07-31 Silva Paul M (SVP & Corp Controller) Option Ex 860 83.36 71,689
2017-07-31 Leiden Jeffrey M (CEO & President) Sale 11,063 153.18 1,694,630
2017-07-31 Leiden Jeffrey M (CEO & President) Option Ex 11,063 45.11 499,051
2017-07-31 Smith Ian F (EVP, CFO & COO) Sale 2,125 153.22 325,598
2017-07-31 Smith Ian F (EVP, CFO & COO) Option Ex 2,125 83.36 177,140
2017-07-21 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 6,900 160.05 1,104,372
2017-07-21 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 12,475 160.80 2,005,980
2017-07-21 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 131.89 280,266
2017-07-21 Silva Paul M (SVP & Corp Controller) Sale 3,437 161.91 556,501
2017-07-21 Sachdev Amit (EVP, CRO) Sale 8,625 160.10 1,380,862
2017-07-21 Leiden Jeffrey M (CEO & President) Sale 32,250 159.86 5,155,420
2017-07-21 Smith Ian F (EVP, CFO & COO) Sale 10,350 160.15 1,657,573
2017-07-19 Parini Michael (EVP, CL&AO) Sale 10,829 161.00 1,743,469
2017-07-19 Parini Michael (EVP, CL&AO) Option Ex 10,829 88.41 957,337
2017-07-19 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 39,833 161.00 6,413,113
2017-07-19 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 38,646 103.00 3,980,731
2017-07-19 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 89,400 161.84 14,468,049
2017-07-19 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 89,400 107.24 9,587,077
2017-07-19 Altshuler David (EVP, Global Research and CSO) Sale 28,979 161.00 4,665,619
2017-07-19 Altshuler David (EVP, Global Research and CSO) Option Ex 28,979 86.30 2,500,742
2017-07-19 Silva Paul M (SVP & Corp Controller) Sale 40,006 161.00 6,440,966
2017-07-19 Silva Paul M (SVP & Corp Controller) Option Ex 40,006 80.23 3,209,841
2017-07-19 Sachdev Amit (EVP, CRO) Sale 20,000 161.00 3,220,000
2017-07-19 Sachdev Amit (EVP, CRO) Option Ex 20,000 77.31 1,546,200
2017-07-19 Leiden Jeffrey M (CEO & President) Sale 184,374 161.00 29,684,214
2017-07-19 Leiden Jeffrey M (CEO & President) Option Ex 184,374 46.92 8,651,749
2017-07-19 Smith Ian F (EVP, CFO & COO) Sale 123,400 161.00 19,867,400
2017-07-19 Smith Ian F (EVP, CFO & COO) Option Ex 123,400 87.15 10,754,063
2017-07-17 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 573 130.28 74,653
2017-07-17 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 573 96.87 55,506
2017-07-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 3,438 127.97 439,978
2017-07-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 3,438 73.51 252,727
2017-06-21 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 5,157 132.87 685,210
2017-06-21 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 5,157 96.87 499,558
2017-06-21 Silva Paul M (SVP & Corp Controller) Sale 2,577 133.36 343,668
2017-06-21 Silva Paul M (SVP & Corp Controller) Option Ex 2,577 83.36 214,818
2017-06-08 Boger Joshua S (Director) Option Ex 2,941 .00 0
2017-06-05 Altshuler David (EVP, Global Research and CSO) Sale 7,500 130.00 975,000
2017-06-05 Altshuler David (EVP, Global Research and CSO) Option Ex 7,500 72.14 541,050
2017-06-02 Bhatia Sangeeta N. (Director) Sale 1,176 128.44 151,045
2017-06-02 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 57,375 129.02 7,402,522
2017-06-02 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 57,375 80.33 4,609,220
2017-06-02 Lee Yuchun (Director) Sale 1,323 128.44 169,926
2017-06-02 Leiden Jeffrey M (CEO & President) Sale 147,101 129.50 19,049,579
2017-06-02 Leiden Jeffrey M (CEO & President) Option Ex 147,101 41.91 6,165,738
2017-06-01 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 5,155 126.87 654,014
2017-06-01 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 5,155 96.87 499,364
2017-06-01 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 13,594 124.00 1,685,656
2017-06-01 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 13,594 53.74 730,541
2017-06-01 Silva Paul M (SVP & Corp Controller) Sale 3,867 127.31 492,307
2017-06-01 Silva Paul M (SVP & Corp Controller) Option Ex 3,867 77.31 298,957
2017-06-01 Sachdev Amit (EVP, CRO) Sale 30,500 125.00 3,812,500
2017-06-01 Sachdev Amit (EVP, CRO) Option Ex 30,500 51.75 1,578,375
2017-06-01 Smith Ian F (EVP, CFO & COO) Sale 98,553 124.00 12,220,572
2017-06-01 Smith Ian F (EVP, CFO & COO) Option Ex 98,553 44.45 4,380,877
2017-05-15 Altshuler David (EVP, Global Research and CSO) Sale 181 114.37 20,700
2017-05-15 Silva Paul M (SVP & Corp Controller) Sale 271 114.64 31,067
2017-05-15 Sachdev Amit (EVP, CRO) Sale 116 114.37 13,266
2017-05-15 Smith Ian F (EVP, CFO & COO) Sale 294 114.92 33,786
2017-05-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 8,979 121.05 1,086,907
2017-05-02 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 8,979 91.05 817,537
2017-04-28 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 28,320 119.50 3,384,240
2017-04-28 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 28,320 45.11 1,277,515
2017-04-28 Altshuler David (EVP, Global Research and CSO) Sale 7,500 120.00 900,000
2017-04-28 Altshuler David (EVP, Global Research and CSO) Option Ex 7,500 63.14 473,550
2017-04-28 Leiden Jeffrey M (CEO & President) Sale 157,200 119.50 18,785,400
2017-04-28 Leiden Jeffrey M (CEO & President) Option Ex 140,034 33.16 4,644,227
2017-04-05 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 8,021 114.00 914,394
2017-04-05 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 8,021 73.51 589,623
2017-04-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 2,291 109.30 250,413
2017-04-03 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 2,291 73.51 168,411
2017-03-29 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 13,750 106.65 1,466,437
2017-03-29 Chodakewitz Jeffrey (EVP GMDA, CMO) Option Ex 13,750 73.51 1,010,762
2017-03-29 Silva Paul M (SVP & Corp Controller) Sale 1,688 106.30 179,434
2017-03-29 Silva Paul M (SVP & Corp Controller) Option Ex 1,688 45.11 76,145
2017-03-29 Sachdev Amit (EVP, CRO) Sale 80,500 108.15 8,706,075
2017-03-29 Sachdev Amit (EVP, CRO) Option Ex 80,500 42.63 3,431,554
2017-02-28 Smith Ian F (EVP, CFO & COO) Sale 3,842 90.00 345,780
2017-02-13 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 5,122 87.67 449,045
2017-02-13 Altshuler David (EVP, Global Research and CSO) Sale 6,403 87.68 561,415
2017-02-13 Sachdev Amit (EVP, CRO) Sale 7,684 87.68 673,733
2017-02-13 Leiden Jeffrey M (CEO & President) Sale 23,904 88.03 2,104,388
2017-02-13 Smith Ian F (EVP, CFO & COO) Sale 3,842 87.66 336,789
2017-02-01 Parini Michael (EVP, CLO & CAO) Sale 3,450 85.98 296,631
2017-02-01 Chodakewitz Jeffrey (EVP GMDA, CMO) Sale 1,900 85.50 162,440
2017-01-11 Boger Joshua S (Director) Sale 8,000 83.15 665,168
2017-01-11 Boger Joshua S (Director) Option Ex 8,000 36.30 290,400

Insider trading activities including stock purchases, stock sales, and option exercises of VRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vertex Pharmaceuticals Inc / Ma (symbol VRTX, CIK number 875320) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.